TrialDiabetologia2026

Empagliflozin improves beta cell function independently of relief of glucotoxicity in patients with type 2 diabetes: results from a randomised cross-over study with insulin as comparator.

Roopameera Thirumathyam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.